Metabolic bone diseases in sickle cell anemia patients and evaluation of associated factors
- PMID: 34256033
- DOI: 10.1016/j.amjms.2021.07.002
Metabolic bone diseases in sickle cell anemia patients and evaluation of associated factors
Abstract
Background: Metabolic or non-metabolic many bone diseases can be distinguished in sickle cell anemia. Patients with sickle cell anemia have a high risk of osteopenia and osteoporosis. The aim of this study is to reveal bone mineral density abnormalities and related factors in patients with sickle cell anemia.
Methods: A total of 70 patients with sickle cell anemia were retrospectively included in our study. Complete blood count (CBC) parameters, serum creatinine, lactate dehydrogenase (LDH), total bilirubin, direct bilirubin, uric acid, calcium, phosphorus, parathormone, alkaline phosphatase, 25 (OH) vitamin D, ferritin, C reactive protein (CRP) and calculated bone mineral densitometry measurements by Dual-Energy X-ray Absorptiometry (DEXA) were assessed and recorded to the statistics program. We diagnosed osteopenia and osteoporosis according to World Health Organization (WHO) criteria. To determine the status of avascular necrosis and bone fracture, we examined x-ray and magnetic resonance imaging reports and epicrisis reports of patients from the records.
Results: The average age was 30.01 ± 8.64 years. Eighteen (26.5%) of the 68 patients whose Z-score was evaluated by DEXA had bone mass below the expected age-related range according to the Z score, while 50 (73.5%) had bone mass within the expected age-related range. Of the patients whose T score was evaluated by DEXA, 46.8% were normal (n=29), 45.1% were osteopenic (n=28) and 8.1% were osteoporotic (n=5).
Conclusions: Patients with sickle cell anemia are at increased risk for osteoporosis, osteopenia, and osteomalacia. Bone health should be emphasized in these patients.
Keywords: Bone mineral density; Osteopenia; Osteoporosis; Sickle cell anemia.
Copyright © 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of İnterest The authors have no conflict of interest.
Similar articles
-
Low bone mass due to sickle cell anemia: is it becoming a real issue?West Afr J Med. 2008 Oct;27(4):218-23. West Afr J Med. 2008. PMID: 19469399
-
Sickle cell anaemia: is it a cause for secondary osteoporosis?West Afr J Med. 2007 Apr-Jun;26(2):134-7. West Afr J Med. 2007. PMID: 17939316
-
Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease.Clinics (Sao Paulo). 2011;66(5):801-5. doi: 10.1590/s1807-59322011000500015. Clinics (Sao Paulo). 2011. PMID: 21789383 Free PMC article.
-
Racial and Ethnic Disparities in Metabolic Bone Disease.Endocrinol Metab Clin North Am. 2023 Dec;52(4):629-641. doi: 10.1016/j.ecl.2023.05.004. Epub 2023 Jun 25. Endocrinol Metab Clin North Am. 2023. PMID: 37865478 Review.
-
Metabolic Bone Diseases: Recommendations for Interventional Radiology.Semin Musculoskelet Radiol. 2024 Oct;28(5):641-650. doi: 10.1055/s-0044-1788580. Epub 2024 Oct 15. Semin Musculoskelet Radiol. 2024. PMID: 39406226 Review.
Cited by
-
Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies.Int J Mol Sci. 2024 Mar 1;25(5):2902. doi: 10.3390/ijms25052902. Int J Mol Sci. 2024. PMID: 38474150 Free PMC article. Review.
-
Iron accumulation induced by hepcidin1 knockout accelerates the progression of aging osteoporosis.J Orthop Surg Res. 2024 Jan 12;19(1):59. doi: 10.1186/s13018-024-04535-z. J Orthop Surg Res. 2024. PMID: 38216929 Free PMC article.
-
Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?Int J Mol Sci. 2023 Nov 13;24(22):16263. doi: 10.3390/ijms242216263. Int J Mol Sci. 2023. PMID: 38003451 Free PMC article. Review.
-
Defects in Bone and Bone Marrow in Inherited Anemias: the Chicken or the Egg.Curr Osteoporos Rep. 2023 Oct;21(5):527-539. doi: 10.1007/s11914-023-00809-3. Epub 2023 Jul 12. Curr Osteoporos Rep. 2023. PMID: 37436584 Review.
-
Low Bone Mass and Recurrent Fractures in Neurofibromatosis With Concomitant Hemoglobin SC Disease.Cureus. 2023 Apr 20;15(4):e37868. doi: 10.7759/cureus.37868. eCollection 2023 Apr. Cureus. 2023. PMID: 37223189 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous